Oxyrane UK Company
Oxyrane UK Limited is a biopharmaceutical company dedicated to the development of novel and biosuperior enzyme replacement therapies (ERT) to treat lysosomal storage diseases, a class of more than 40 rare, inherited diseases. Founded in 2006, the Company is headquartered in Manchester, United Kingdom with research facilities in Ghent, Belgium.
Headquarters:
Manchester, Manchester, United Kingdom
Last Funding Type:
Series D
Investors Number:
3
Last Funding Date:
11-17-2011
Employee Number:
11-50
Total Funding:
£16 721 500
Founded Date:
2007
Estimated Revenue:
£7 800 000-38 990 000
Industry:
PharmTech
Funding Status:
Late Stage Venture